Other
2027
Merck & Co. 2027 increased by 58.3% to $3.80B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 58.3%, from $2.40B to $3.80B. Over 5 years (FY 2020 to FY 2025), 2027 shows an upward trend with a 20.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2025Feb 24, 2026
How to read this metric
Lower projected expenses indicate a reduction in the drag on future net income as assets become fully amortized.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2027. These assets ty...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_a31c97Historical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $1.70B | $1.80B | $1.80B | $2.40B | $3.80B |
| QoQ Change | — | +5.9% | +0.0% | +33.3% | +58.3% |
| YoY Change | — | +5.9% | +0.0% | +33.3% | +58.3% |
Range$1.70B – $3.80B
CAGR+123.5%
Avg YoY Growth+24.4%
Median YoY Growth+19.6%
Current Streak4+ quarters growth
2027 at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s 2027?
- Merck & Co. (MRK) reported 2027 of $3.80B in Q4 2025.
- How has Merck & Co.'s 2027 changed year-over-year?
- Merck & Co.'s 2027 increased by 58.3% year-over-year, from $2.40B to $3.80B.
- What is the long-term trend for Merck & Co.'s 2027?
- Over 5 years (2020 to 2025), Merck & Co.'s 2027 has grown at a 20.4% compound annual growth rate (CAGR), from $1.50B to $3.80B.
- What does 2027 mean?
- The expected non-cash expense for acquired intangible assets in the year 2027.